Ding, Naiqing
52  results:
Search for persons X
?
1

Membrane fusogenic nanoparticle‐based HLA‐peptide‐addressin..:

Xu, Ruihan ; Wang, Qin ; Zhu, Junmeng...
Bioengineering & Translational Medicine.  8 (2023)  6 - p. , 2023
 
?
2

Individualised adjuvant immunotherapy with neoantigen‐react..:

Ding, Naiqing ; Liu, Qin ; Du, Juan...
Clinical & Translational Immunology.  12 (2023)  9 - p. , 2023
 
?
5

In situ antigen modification-based target-redirected univer..:

Sun, Zhichen ; Li, Rutian ; Shen, Yun...
Journal of Hematology & Oncology.  15 (2022)  1 - p. , 2022
 
?
 
?
9

Bifunctional iRGD-anti-CD3 enhances antitumor potency of T ..:

Zhou, Shujuan ; Meng, Fanyan ; Du, Shiyao...
Journal for ImmunoTherapy of Cancer.  9 (2021)  5 - p. e001925 , 2021
 
?
10

Immune-Mediated Antitumor Effect By VEGFR2 Selective Inhibi..:

Yang, Ju ; Yan, Jing ; Shao, Jie...
OncoTargets and Therapy.  12 (2019)  - p. 9757-9765 , 2019
 
?
12

Lipid insertion enables targeted functionalization of pacli..:

Chen, Hong ; Sha, Huizi ; Zhang, Lianru...
International Journal of Nanomedicine.  13 (2018)  - p. 5347-5359 , 2018
 
?
13

Microcystin (-LR) induced testicular cell apoptosis via up-..:

Wang, Xueting ; Chen, Yu ; Zuo, Xintong...
Food and Chemical Toxicology.  60 (2013)  - p. 309-317 , 2013
 
?
14

Individualised adjuvant immunotherapy with neoantigen‐react..:

Ding, Naiqing ; Liu, Qin ; Du, Juan...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10494288/.  , 2023
 
?
15

Neoadjuvant sintilimab in combination with concurrent chemo..:

Wei, Jia ; Lu, Xiaofeng ; Liu, Qin...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10425436/.  , 2023
 
1-15